TrialPediatric blood & cancer2011

Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.

Beverly J Lange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.